147 related articles for article (PubMed ID: 20207139)
1. Structure-based design of novel human Pin1 inhibitors (II).
Dong L; Marakovits J; Hou X; Guo C; Greasley S; Dagostino E; Ferre R; Johnson MC; Kraynov E; Thomson J; Pathak V; Murray BW
Bioorg Med Chem Lett; 2010 Apr; 20(7):2210-4. PubMed ID: 20207139
[TBL] [Abstract][Full Text] [Related]
2. Structure-based design of novel human Pin1 inhibitors (I).
Guo C; Hou X; Dong L; Dagostino E; Greasley S; Ferre R; Marakovits J; Johnson MC; Matthews D; Mroczkowski B; Parge H; Vanarsdale T; Popoff I; Piraino J; Margosiak S; Thomson J; Los G; Murray BW
Bioorg Med Chem Lett; 2009 Oct; 19(19):5613-6. PubMed ID: 19729306
[TBL] [Abstract][Full Text] [Related]
3. Structure-based design of novel human Pin1 inhibitors (III): optimizing affinity beyond the phosphate recognition pocket.
Guo C; Hou X; Dong L; Marakovits J; Greasley S; Dagostino E; Ferre R; Johnson MC; Humphries PS; Li H; Paderes GD; Piraino J; Kraynov E; Murray BW
Bioorg Med Chem Lett; 2014 Sep; 24(17):4187-91. PubMed ID: 25091930
[TBL] [Abstract][Full Text] [Related]
4. Structure-guided design of alpha-amino acid-derived Pin1 inhibitors.
Potter AJ; Ray S; Gueritz L; Nunns CL; Bryant CJ; Scrace SF; Matassova N; Baker L; Dokurno P; Robinson DA; Surgenor AE; Davis B; Murray JB; Richardson CM; Moore JD
Bioorg Med Chem Lett; 2010 Jan; 20(2):586-90. PubMed ID: 19969456
[TBL] [Abstract][Full Text] [Related]
5. Discovery and characterization of a nonphosphorylated cyclic peptide inhibitor of the peptidylprolyl isomerase, Pin1.
Duncan KE; Dempsey BR; Killip LE; Adams J; Bailey ML; Lajoie GA; Litchfield DW; Brandl CJ; Shaw GS; Shilton BH
J Med Chem; 2011 Jun; 54(11):3854-65. PubMed ID: 21545152
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of the novel elemonic acid derivatives as Pin1 inhibitors.
Li X; Li L; Zhou Q; Zhang N; Zhang S; Zhao R; Liu D; Jing Y; Zhao L
Bioorg Med Chem Lett; 2014 Dec; 24(24):5612-5615. PubMed ID: 25466185
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of novel quinazoline-derived human Pin1 inhibitors.
Zhu L; Jin J; Liu C; Zhang C; Sun Y; Guo Y; Fu D; Chen X; Xu B
Bioorg Med Chem; 2011 May; 19(9):2797-807. PubMed ID: 21504850
[TBL] [Abstract][Full Text] [Related]
8. [Design, synthesis and biological evaluation of novel diaryl ethers bearing a pyrimidine motif as human Pin1 inhibitors].
Xi YY; Jin J; Sun Y; Chen XG; Song HR; Xu BL
Yao Xue Xue Bao; 2013 Aug; 48(8):1266-72. PubMed ID: 24187834
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of novel human Pin1 inhibitors with benzophenone skeleton.
Liu C; Jin J; Chen L; Zhou J; Chen X; Fu D; Song H; Xu B
Bioorg Med Chem; 2012 May; 20(9):2992-9. PubMed ID: 22459212
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for high-affinity peptide inhibition of human Pin1.
Zhang Y; Daum S; Wildemann D; Zhou XZ; Verdecia MA; Bowman ME; Lücke C; Hunter T; Lu KP; Fischer G; Noel JP
ACS Chem Biol; 2007 May; 2(5):320-8. PubMed ID: 17518432
[TBL] [Abstract][Full Text] [Related]
11. Pin1 inhibitors: Pitfalls, progress and cellular pharmacology.
Moore JD; Potter A
Bioorg Med Chem Lett; 2013 Aug; 23(15):4283-91. PubMed ID: 23796453
[TBL] [Abstract][Full Text] [Related]
12. A reduced-amide inhibitor of Pin1 binds in a conformation resembling a twisted-amide transition state.
Xu GG; Zhang Y; Mercedes-Camacho AY; Etzkorn FA
Biochemistry; 2011 Nov; 50(44):9545-50. PubMed ID: 21980916
[TBL] [Abstract][Full Text] [Related]
13. [Recent advances in the study of pin1 and its inhibitors].
Zhang CJ; Zhang ZH; Xu BL; Wang YL
Yao Xue Xue Bao; 2008 Jan; 43(1):9-17. PubMed ID: 18357725
[TBL] [Abstract][Full Text] [Related]
14. Dipentamethylene thiuram monosulfide is a novel inhibitor of Pin1.
Tatara Y; Lin YC; Bamba Y; Mori T; Uchida T
Biochem Biophys Res Commun; 2009 Jul; 384(3):394-8. PubMed ID: 19422802
[TBL] [Abstract][Full Text] [Related]
15. Modulating the Affinities of Phosphopeptides for the Human Pin1 WW Domain Using 4-Substituted Proline Derivatives.
Huang KY; Horng JC
Biochemistry; 2015 Oct; 54(40):6186-94. PubMed ID: 26406962
[TBL] [Abstract][Full Text] [Related]
16. Conformationally locked isostere of phosphoSer-cis-Pro inhibits Pin1 23-fold better than phosphoSer-trans-Pro isostere.
Wang XJ; Xu B; Mullins AB; Neiler FK; Etzkorn FA
J Am Chem Soc; 2004 Dec; 126(47):15533-42. PubMed ID: 15563182
[TBL] [Abstract][Full Text] [Related]
17. Control of protein-protein interactions: structure-based discovery of low molecular weight inhibitors of the interactions between Pin1 WW domain and phosphopeptides.
Smet C; Duckert JF; Wieruszeski JM; Landrieu I; Buée L; Lippens G; Déprez B
J Med Chem; 2005 Jul; 48(15):4815-23. PubMed ID: 16033261
[TBL] [Abstract][Full Text] [Related]
18. Discovery of cell-active phenyl-imidazole Pin1 inhibitors by structure-guided fragment evolution.
Potter A; Oldfield V; Nunns C; Fromont C; Ray S; Northfield CJ; Bryant CJ; Scrace SF; Robinson D; Matossova N; Baker L; Dokurno P; Surgenor AE; Davis B; Richardson CM; Murray JB; Moore JD
Bioorg Med Chem Lett; 2010 Nov; 20(22):6483-8. PubMed ID: 20932746
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation-dependent proline isomerization catalyzed by Pin1 is essential for tumor cell survival and entry into mitosis.
Rippmann JF; Hobbie S; Daiber C; Guilliard B; Bauer M; Birk J; Nar H; Garin-Chesa P; Rettig WJ; Schnapp A
Cell Growth Differ; 2000 Jul; 11(7):409-16. PubMed ID: 10939594
[TBL] [Abstract][Full Text] [Related]
20. Thermodynamics of phosphopeptide binding to the human peptidyl prolyl cis/trans isomerase Pin1.
Daum S; Fanghänel J; Wildemann D; Schiene-Fischer C
Biochemistry; 2006 Oct; 45(39):12125-35. PubMed ID: 17002312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
